Home › Trials › NCT05987410
Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Rehabilitation with Nordic Walking for overweight and obese patients

Official title: EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Diabetic patiEnts With Cardiovascular Disease. The VENERE Study

Run by Fondazione Don Carlo Gnocchi ETS · NCT05987410 · Data updated 2026-11-12

This study tests if Nordic Walking can help overweight and obese patients with diabetes and heart issues get fitter and feel better while also receiving standard rehabilitation support.

More Cardiovascular Diseases trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment105 (estimated)
SponsorFondazione Don Carlo Gnocchi ETS
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Milan)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedSeptember 30, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 3, 2026
Trial IDNCT05987410 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include overweight or obese adults with a BMI of 27 kg/m2 or higher, who have diabetes and have experienced a recent cardiovascular event.

Probably not a fit

Patients who are unable to walk independently or have acute joint or spine pathologies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Nordic Walking (NW) as a rehabilitation method for overweight and obese patients with diabetes and recent cardiovascular events. NW combines walking with the use of special sticks, increasing caloric expenditure and engaging a majority of the body's muscles while minimizing stress on joints. The program aims to improve various fitness components, including coordination, endurance, strength, and mobility, under the guidance of an instructor. Participants will also receive standard rehabilitation and cardiological counseling as part of their treatment.

Why it matters

Potential benefit: If successful, this approach could enhance rehabilitation outcomes and overall health for patients with obesity and cardiovascular issues.

How similar studies have gone: Previous studies have shown positive outcomes with similar rehabilitation approaches, suggesting potential for success in this study.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

\- overweight \[Body Mass Index (BMI) ≥ 27 kg/m2\] or obese (BMI ≥30 kg/m2) adult patients with diabetes mellitus and with a recent cardiovascular event and/or coronary revascularization in the previous three months

Exclusion Criteria:

* inability to walk independently and constantly;
* acute joint or spine pathologies that make movement impossible;
* the presence of dementia as approved by consultation of the patient's medical record and/or administration of the Montreal Cognitive Assessment (MOCA) test ≤ 15.5 (Nasreddine et al., 2005);
* chemotherapy 6 months before surgery;
* advanced renal failure;
* acute cardiovascular event \< 3 months (unstable angina, AMI with FE \<40%, arrhythmias, valvular disease, intracerebral/subdural haemorrhage, uncontrolled AI);
* home oxygen therapy and Non-Invasive Ventilation (NIV) \[excluding Continuous Positive Airway Pressure (CPAP)\].

Where it's running

  • IRCCS Fondazione Don Carlo Gnocchi
    Milan, Italy     Recruiting

Study contacts

  • Principal investigator: Anna Torri, MD — IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy
  • Study coordinator: Nuccia Morici, MD, Ph.D.
  • Email: nmorici@dongnocchi.it
  • Phone: 3206359064

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Cardiovascular Diseases 365Diabete Type 2 24Overweight and Obesity 70Fondazione Don Carlo Gnocchi ETS 39
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.